128 related articles for article (PubMed ID: 26800504)
1. ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.
Ota M; Mochizuki S; Shimoda M; Abe H; Miyamae Y; Ishii K; Kimura H; Okada Y
Cancer Sci; 2016 Apr; 107(4):433-43. PubMed ID: 26800504
[TBL] [Abstract][Full Text] [Related]
2. ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis.
Verbisck NV; Costa ET; Costa FF; Cavalher FP; Costa MD; Muras A; Paixão VA; Moura R; Granato MF; Ierardi DF; Machado T; Melo F; Ribeiro KB; Cunha IW; Lima VC; Maciel Mdo S; Carvalho AL; Soares FF; Zanata S; Sogayar MC; Chammas R; Camargo AA
Cancer Res; 2009 Jul; 69(13):5546-52. PubMed ID: 19549921
[TBL] [Abstract][Full Text] [Related]
3. Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity.
Akunuru S; Palumbo J; Zhai QJ; Zheng Y
PLoS One; 2011 Feb; 6(2):e16951. PubMed ID: 21347385
[TBL] [Abstract][Full Text] [Related]
4. The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma.
Hu C; Lv H; Pan G; Cao H; Deng Z; Hu C; Wen J; Zhou J
Int J Exp Pathol; 2011 Oct; 92(5):333-9. PubMed ID: 21429053
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell expression of ADAM23 governs T cell proliferation and cytokine production through the α(v)β(3) integrin receptor.
Elizondo DM; Andargie TE; Marshall KM; Zariwala AM; Lipscomb MW
J Leukoc Biol; 2016 Nov; 100(5):855-864. PubMed ID: 27317750
[TBL] [Abstract][Full Text] [Related]
6. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.
Choi JS; Kim KH; Jeon YK; Kim SH; Jang SG; Ku JL; Park JG
Int J Cancer; 2009 Mar; 124(6):1258-62. PubMed ID: 19089928
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Kawano T; Yonezawa H; Rokutanda S; Naruse T; Umeda M
Oral Oncol; 2011 Sep; 47(9):855-60. PubMed ID: 21757396
[TBL] [Abstract][Full Text] [Related]
10. Detection of putative cancer stem cells of the side population phenotype in human tumor cell cultures.
Christgen M; Ballmaier M; Lehmann U; Kreipe H
Methods Mol Biol; 2012; 878():201-15. PubMed ID: 22674135
[TBL] [Abstract][Full Text] [Related]
11. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
[TBL] [Abstract][Full Text] [Related]
12. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
Wang FF; Wang S; Xue WH; Cheng JL
Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
[TBL] [Abstract][Full Text] [Related]
13. Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity.
Nam A; Jain S; Wu C; Campos A; Shepard RM; Yu Z; Reddy JP; Von Schalscha T; Weis SM; Onaitis M; Wettersten HI; Cheresh DA
Cancer Res; 2024 May; 84(10):1630-1642. PubMed ID: 38588407
[TBL] [Abstract][Full Text] [Related]
14. ADAM23 knockdown promotes neuronal differentiation of P19 embryonal carcinoma cells by up-regulating P27KIP1 expression.
Wang Y; Sun Y; Qiao S
Cell Biol Int; 2012; 36(12):1275-9. PubMed ID: 22973984
[TBL] [Abstract][Full Text] [Related]
15. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
16. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
17. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
[TBL] [Abstract][Full Text] [Related]
18. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibody DL11C8 Identifies ADAM23 as a Component of Lipid Raft Microdomains.
Borgonovo ZLM; Ribeiro CF; Costa MDM; Souza ILM; Rossi GR; Alcantara MV; Ingberman M; Braga LG; Mercadante AF; Nakao LS; Zanata SM
Neuroscience; 2018 Aug; 384():165-177. PubMed ID: 29792904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
